Print Page   |   Contact Us   |   Sign In   |   Join
News and Press: Member Organization News

Cardiovascular Biotech Gemphire Therapeutics Files for a $60 million IPO

Tuesday, April 19, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

Gemphire Therapeutics, a cardiovascular biotech developing therapies for the treatment of dyslipidemia, filed on Monday with the SEC to raise up to $60 million in an initial public offering.


Read more.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal